Search Results for 'Drug-Ftc'

Drug-Ftc published presentations and documents on DocSlides.

DTG + TAF/FTC vs DTG + TDF/FTC vs EFV/TDF/FTC
DTG + TAF/FTC vs DTG + TDF/FTC vs EFV/TDF/FTC
by iris
ADVANCE. . Design. Primary endpoint. Proportion ...
Comments of Prescription Access Litigation Project and Others on FTC P
Comments of Prescription Access Litigation Project and Others on FTC P
by jainy
almost-inevitable patent infringement lawsuit from...
TDF-FTC versus Placebo as HIV PrEP for Transgender Women
TDF-FTC versus Placebo as HIV PrEP for Transgender Women
by shmuel184
iPrEx. Trial . Substudy. TDF-FTC versus Placebo a...
x0000x00002  xMCIxD 0 xMCIxD 0 high rate of drug company consolidati
x0000x00002 xMCIxD 0 xMCIxD 0 high rate of drug company consolidati
by elizabeth
SeeJustus Haucap Joel Stiebale Research Innovatio...
Raltegravir + Darunavir/r versus TDF-FTC + Darunavir/r RADAR Trial
Raltegravir + Darunavir/r versus TDF-FTC + Darunavir/r RADAR Trial
by keanu817
RADAR Trial. Raltegravir. + Darunavir/r versus TD...
Switch from Efavirenz + ZDV-3TC to Efavirenz + TDF-FTC
Switch from Efavirenz + ZDV-3TC to Efavirenz + TDF-FTC
by ramon803
SWEET Trial . Switch to Efavirenz + TDF-FTC . SWEE...
Elvitegravir-Cobicistat-TAF-FTC in Renal Impairment
Elvitegravir-Cobicistat-TAF-FTC in Renal Impairment
by carl
Study 112. Elvitegravir-Cobicistat-TAF-FTC in Rena...
Switching from TDF/FTC to TAF/
Switching from TDF/FTC to TAF/
by fanny
FTC. Study 311-1089. Switching from TDF/FTC to TAF...
Switching to TDF-FTC  from ABC-3TC for Hyperlipidemia
Switching to TDF-FTC from ABC-3TC for Hyperlipidemia
by trinity
ROCKET II. Switching to TDF-FTC from ABC-3TC . for...
DTG + 3TC versus DTG + TDF-FTC as Initial ART
DTG + 3TC versus DTG + TDF-FTC as Initial ART
by della
GEMINI 1 and GEMINI 2: Week 48 Data. DTG + 3TC . v...
Elvitegravir-Cobicistat-TAF-FTC in Hepatitis B Coinfection
Elvitegravir-Cobicistat-TAF-FTC in Hepatitis B Coinfection
by melanie
Study 1249. Elvitegravir-Cobicistat-TAF-FTC in HIV...
FTCA Coverage for Individuals at Free Clinics
FTCA Coverage for Individuals at Free Clinics
by phoebe-click
Technical Assistance Call. PIN 2010-02. Departmen...
Switch to EVG/c/FTC/TDF
Switch to EVG/c/FTC/TDF
by liane-varnes
STRATEGY-PI . Study. STRATEGY-NNRTI . Study. Desi...
FTC Driver Station
FTC Driver Station
by faustina-dinatale
Setup and Operatio. n. Mike Zook . 20-Sep-2016. H...
AI in Drug Development: UAE Pharmaceutical R&D Intelligence Guide
AI in Drug Development: UAE Pharmaceutical R&D Intelligence Guide
by Pubrica106
Download pubrica’s comprehensive guide on AI in ...
Optimization of Antiretroviral Therapy
Optimization of Antiretroviral Therapy
by belinda
With Emergence of Comorbidities. Roger J. . Bedimo...
HIV 2020:  Time for change
HIV 2020: Time for change
by garcia
Dr. Kay Mahomed. Netcare. Garden City Clinic. Ma...
HIV Medicine From Guidelines to Practice
HIV Medicine From Guidelines to Practice
by jubilantbikers
Kiat. . Ruxrungtham. Professor of Medicine, . Chu...
CROI Update: Best of Boston
CROI Update: Best of Boston
by triclin
p. resented by. NCATEC. March . 18, . 2014. David ...
Pre-Exposure Prophylaxis ( PrEP )  for HIV Infection Jeffrey D. Klausner, MD, MPH
Pre-Exposure Prophylaxis ( PrEP ) for HIV Infection Jeffrey D. Klausner, MD, MPH
by kittie-lecroy
Pre-Exposure Prophylaxis ( PrEP ) for HIV Infect...
Florida  AIDS Drug Assistance
Florida AIDS Drug Assistance
by natalia-silvester
Program. Improving Health. . . Promoting Wellness...
Florida  AIDS Drug Assistance
Florida AIDS Drug Assistance
by yoshiko-marsland
Program. Improving Health. . . Promoting Wellness...
Does Pharmacology Support On Demand
Does Pharmacology Support On Demand
by min-jolicoeur
PrEP. ?. Angela DM Kashuba. UNC Eshelman School o...
HIV Medicine From Guidelines to Practice
HIV Medicine From Guidelines to Practice
by cheryl-pisano
Kiat. . Ruxrungtham. Professor of Medicine, . Ch...
Comprehensive  Guideline Summary
Comprehensive Guideline Summary
by aaron
Guidelines for the Use of Antiretroviral Agents. ...
ART Initiation:  PrEP  and
ART Initiation: PrEP and
by alida-meadow
Treatment-naïve Patients . Clinical Instructor, ...
Florida  AIDS Drug Assistance
Florida AIDS Drug Assistance
by liane-varnes
Program. Improving Health. . . Promoting Wellness...
Clinical  Management Module
Clinical Management Module
by stefany-barnette
4. . (b) . Risks and Side Effects. Overview. Res...
Phase 2 of new ARVs
Phase 2 of new ARVs
by mitsue-stanley
Fostemsavir. , . prodrug. of . temsavir. . (. a...
Cases from the Clinic(ians):  Case-based Panel Discussion
Cases from the Clinic(ians): Case-based Panel Discussion
by tripp
Associate Dean for Global Health. University of Al...
Switch from EFV plus ABC-3TC to EFV-TDF-FTC ROCKET-1 Trial
Switch from EFV plus ABC-3TC to EFV-TDF-FTC ROCKET-1 Trial
by ricardo
ROCKET-1 Trial. Switch from EFV + ABC-3TC to EFV-T...
When and What To Start Melanie A. Thompson, MD
When and What To Start Melanie A. Thompson, MD
by paxton651
Thacker & Thompson, MD. Atlanta, Georgia. Fina...
Atazanavir + [Cobicistat or Ritonavir] + TDF-FTC (Phase 2)
Atazanavir + [Cobicistat or Ritonavir] + TDF-FTC (Phase 2)
by zane419
Study 105. Atazanavir + [Cobicistat or Ritonavir] ...
Thinking of Now and Tomorrow: Emerging Treatment Paradigms
Thinking of Now and Tomorrow: Emerging Treatment Paradigms
by deena
Pedro Cahn. Disclosures. Advisory. . boards. : Me...
Cabotegravir, Long-acting Injectable
Cabotegravir, Long-acting Injectable
by jacey
Last Updated: October 6, 2023. Prepared by:. David...
Jeanne Marrazzo, MD, MPH
Jeanne Marrazzo, MD, MPH
by rose
Professor of Medicine. University of Washington. S...
Introduction Characteristics, Treatment Patterns,
Introduction Characteristics, Treatment Patterns,
by cappi
and . Virologic. Outcomes . for Treatment-experie...
PrEP  to Prevent HIV and
PrEP to Prevent HIV and
by kimberly
Promote Sexual Health. www.hivguidelines.org. MAY ...